Skip to main content
. 2014 Dec;104(12):2328–2333. doi: 10.2105/AJPH.2014.302043

TABLE 2—

Bivariate and Multivariable Survey Logistic Regression to Examine Screening and Access to Health Care as Predictors of Medication Continuity in US Prisons: 2004 Survey of Inmates in State and Federal Correctional Facilities

Variable Bivariate Model: Medication Use at Admission and in Prison (Continuity), OR (95% CI) Multivariable Model: Medication Use at Admission and in Prison (Continuity), OR (95% CI)
Access to and use of medical treatment in prison
 Saw a health care professional at any point while incarcerated 1.20 (0.95, 1.52) 1.36* (1.06, 1.75)
 Screened about health or medical history 1.49** (1.17, 1.89) 1.17 (0.89, 1.55)
Mental health conditionsa
 Depression (Ref) 1.00 1.00
 Mania 1.18 (0.92, 1.52) . . .
 Schizophrenia 1.79*** (1.34, 2.40) 2.26*** (1.50, 3.40)
 Posttraumatic stress disorder 1.24 (0.90, 1.70) . . .
 Anxiety 0.96 (0.72, 1.26) . . .
 Personality disorders 1.17 (0.83, 1.65) . . .
 Other mental health disorders 1.08 (0.59, 1.98) . . .
Race
 Non-Hispanic White (Ref) 1.00 1.00
 Non-Hispanic Black 1.05*** (1.26, 1.79) 1.36* (1.05, 1.78)
 Non-Hispanic other 1.17 (0.94, 1.45) 1.02 (0.66, 1.58)
 Hispanic 0.95 (0.71, 1.28) 0.92 (0.68, 1.25)
Sex (male) 0.87 (0.76, 1.03) 0.94 (0.75, 1.18)
Age 1.03*** (1.02, 1.04) 1.02*** (1.02, 1.04)
Time served 0.98 (0.96, 1.01) 0.97* (0.95, 0.99)
State institution 0.87 (0.72, 1.07) 0.96 (0.73, 1.26)

Note. CI = confidence interval; OR = odds ratio. The sample comprised all prisoners who reported having taken medication at the time of admission to the facility (n = 3718).

a

Because of the low prevalence of several mental health conditions, multivariable analyses were conducted for only schizophrenia and depression (reference). All other analyses were not related to treatment continuity; therefore, only bivariate analyses for rare mental health conditions are presented here.

*P < .05; **P < .01; ***P < .001